ARTICLE | Financial News

Taris Biomedical raises $32M series A

October 28, 2015 2:07 AM UTC

Taris Biomedical LLC (Lexington, Mass.) raised $32 million in a series A round led by existing investor Flagship Ventures. Existing investor Polaris Venture Partners and new investor RA Capital also participated. Taris Biomedical LLC was formed to house the remaining assets of Taris Biomedical Inc. after Allergan plc (NYSE:AGN) acquired lead program LiRIS in August 2014 (see BioCentury Extra, Aug. 14, 2014). ...